Cargando…

Altersepilepsie: Herausforderungen in Diagnostik und Therapie

Epilepsy is the third most frequent neurological disorder in aged patients after stroke and dementia. The incidence of epilepsy increases with age with the highest rates in patients ≥ 65 years old. Due to demographic changes the number of aged patients with epilepsy is expected to increase further i...

Descripción completa

Detalles Bibliográficos
Autores principales: Rohracher, Alexandra, Trinka, Eugen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2021
Materias:
CME
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222019/
https://www.ncbi.nlm.nih.gov/pubmed/33891210
http://dx.doi.org/10.1007/s00391-021-01882-y
_version_ 1783711423497502720
author Rohracher, Alexandra
Trinka, Eugen
author_facet Rohracher, Alexandra
Trinka, Eugen
author_sort Rohracher, Alexandra
collection PubMed
description Epilepsy is the third most frequent neurological disorder in aged patients after stroke and dementia. The incidence of epilepsy increases with age with the highest rates in patients ≥ 65 years old. Due to demographic changes the number of aged patients with epilepsy is expected to increase further in the coming years. The leading cause of new onset epilepsy in aged patients is cerebrovascular disease followed by dementia. The recognition of seizures in aged patients is often delayed. Status epilepticus occurs more frequently in aged patients and is associated with a high mortality and morbidity. Antiepileptic drug (AED) treatment of aged patients is complicated by comorbidities and polypharmacy and AEDs with a low interaction profile and high tolerability should be selected. Levetiracetam and lamotrigine are the AEDs of choice due to low interactions and good tolerability.
format Online
Article
Text
id pubmed-8222019
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-82220192021-06-28 Altersepilepsie: Herausforderungen in Diagnostik und Therapie Rohracher, Alexandra Trinka, Eugen Z Gerontol Geriatr CME Epilepsy is the third most frequent neurological disorder in aged patients after stroke and dementia. The incidence of epilepsy increases with age with the highest rates in patients ≥ 65 years old. Due to demographic changes the number of aged patients with epilepsy is expected to increase further in the coming years. The leading cause of new onset epilepsy in aged patients is cerebrovascular disease followed by dementia. The recognition of seizures in aged patients is often delayed. Status epilepticus occurs more frequently in aged patients and is associated with a high mortality and morbidity. Antiepileptic drug (AED) treatment of aged patients is complicated by comorbidities and polypharmacy and AEDs with a low interaction profile and high tolerability should be selected. Levetiracetam and lamotrigine are the AEDs of choice due to low interactions and good tolerability. Springer Medizin 2021-04-23 2021 /pmc/articles/PMC8222019/ /pubmed/33891210 http://dx.doi.org/10.1007/s00391-021-01882-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access Dieser Artikel wird unter der Creative Commons Namensnennung 4.0 International Lizenz veröffentlicht, welche die Nutzung, Vervielfältigung, Bearbeitung, Verbreitung und Wiedergabe in jeglichem Medium und Format erlaubt, sofern Sie den/die ursprünglichen Autor(en) und die Quelle ordnungsgemäß nennen, einen Link zur Creative Commons Lizenz beifügen und angeben, ob Änderungen vorgenommen wurden. Die in diesem Artikel enthaltenen Bilder und sonstiges Drittmaterial unterliegen ebenfalls der genannten Creative Commons Lizenz, sofern sich aus der Abbildungslegende nichts anderes ergibt. Sofern das betreffende Material nicht unter der genannten Creative Commons Lizenz steht und die betreffende Handlung nicht nach gesetzlichen Vorschriften erlaubt ist, ist für die oben aufgeführten Weiterverwendungen des Materials die Einwilligung des jeweiligen Rechteinhabers einzuholen. Weitere Details zur Lizenz entnehmen Sie bitte der Lizenzinformation auf http://creativecommons.org/licenses/by/4.0/deed.de (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle CME
Rohracher, Alexandra
Trinka, Eugen
Altersepilepsie: Herausforderungen in Diagnostik und Therapie
title Altersepilepsie: Herausforderungen in Diagnostik und Therapie
title_full Altersepilepsie: Herausforderungen in Diagnostik und Therapie
title_fullStr Altersepilepsie: Herausforderungen in Diagnostik und Therapie
title_full_unstemmed Altersepilepsie: Herausforderungen in Diagnostik und Therapie
title_short Altersepilepsie: Herausforderungen in Diagnostik und Therapie
title_sort altersepilepsie: herausforderungen in diagnostik und therapie
topic CME
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222019/
https://www.ncbi.nlm.nih.gov/pubmed/33891210
http://dx.doi.org/10.1007/s00391-021-01882-y
work_keys_str_mv AT rohracheralexandra altersepilepsieherausforderungenindiagnostikundtherapie
AT trinkaeugen altersepilepsieherausforderungenindiagnostikundtherapie